venlafaxine hydrochloride
venlafaxine hydrochloride is listed in the FDA National Drug Code directory with 49 NDC codes, marketed under brand names including venlafaxine hydrochloride, Venlafaxine Hydrochloride, venlafaxine. Available dosage forms: capsule, extended release, tablet, extended release, tablet, powder.
Drug details
- Generic Name
- venlafaxine hydrochloride
- Brand Names
- venlafaxine hydrochloride, Venlafaxine Hydrochloride, venlafaxine
- Application Number
- ANDA078421
- Sponsor
- Dr.Reddys Laboratories Inc
- NDC Codes
- 49
- Dosage Forms
- CAPSULE, EXTENDED RELEASE, TABLET, EXTENDED RELEASE, TABLET, POWDER
- Routes
- ORAL
- Active Ingredients
- VENLAFAXINE HYDROCHLORIDE
Indications and Usage
1 INDICATIONS AND USAGE Venlafaxine hydrochloride extended-release capsules are indicated in adults for the treatment of: • Major Depressive Disorder (MDD) [see Clinical Studies ( 14.1 )] • Generalized Anxiety Disorder (GAD) [see Clinical Studies ( 14.2 )] • Social Anxiety Disorder (SAD) [see Clinical Studies ( 14.3 )] • Panic Disorder (PD) [see Clinical Studies ( 14.4 )] Venlafaxine hydrochloride extended-release capsules are a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of adults with: • Major Depressive Disorder (MDD) ( 1 ) • Generalized Anxiety Disorder (GAD) ( 1 ) • Social Anxiety Disorder (SAD) ( 1 ) • Panic Disorder (PD) ( 1 )